Population Structure and Capsular Switching of InvasiveNeisseria meningitidisIsolates in the Pre–Meningococcal Conjugate Vaccine Era—United States, 2000–2005
Open Access
- 15 April 2010
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 201 (8) , 1208-1224
- https://doi.org/10.1086/651505
Abstract
Background. A quadrivalent meningococcal conjugate vaccine (MCV4) was licensed in the United States in 2005; no serogroup B vaccine is available. NeiKeywords
This publication has 43 references indexed in Scilit:
- Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adultsVaccine, 2007
- Prospects for Vaccine Prevention of Meningococcal InfectionClinical Microbiology Reviews, 2006
- Postvaccine Genetic Structure ofStreptococcus pneumoniaeSerotype 19A from Children in the United StatesThe Journal of Infectious Diseases, 2005
- Potential Capsule Switching from Serogroup Y to B: The Characterization of Three such Neisseria meningitidis Isolates Causing Invasive Meningococcal Disease in CanadaCanadian Journal of Infectious Diseases and Medical Microbiology, 2005
- mlstdbNet – distributed multi-locus sequence typing (MLST) databasesBMC Bioinformatics, 2004
- Use of Real-Time PCR To Resolve Slide Agglutination Discrepancies in Serogroup Identification of Neisseria meningitidisJournal of Clinical Microbiology, 2004
- Meningococcal DiseaseNew England Journal of Medicine, 2001
- Active Bacterial Core Surveillance of the Emerging Infections Program NetworkEmerging Infectious Diseases, 2001
- Differential Distribution of Novel Restriction-Modification Systems in Clonal Lineages of Neisseria meningitidisJournal of Bacteriology, 2000
- Epidemic Serogroup B Meningococcal Disease in OregonPublished by American Medical Association (AMA) ,1999